Gunilla Rask
Umea, AC 90185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Breast cancer liver metastases and the impact of receptor expression on survival.
Journal: Clinical & experimental metastasis
Published: August 18, 2026
Breast cancer liver metastases and the impact of receptor expression on survival.
Journal: Clinical & experimental metastasis
Published: October 16, 2025
Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study.
Journal: Breast cancer research : BCR
Published: September 07, 2025
Corrigendum to Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
Journal: The Journal of clinical investigation
Published: August 04, 2025
Stromal collagen IV expression and risk of breast cancer death in ductal carcinoma in situ.
Journal: BJC reports
Published: May 21, 2025
Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment.
Journal: Breast (Edinburgh, Scotland)
Published: February 25, 2025
A bottom-up initiated digital external quality assessment scheme for the state-of-the-art pathology in Sweden: reduced variability between pathology departments.
Journal: Virchows Archiv : an international journal of pathology
Published: January 17, 2025
The potential role of collagen type VII in breast cancer proliferation.
Journal: Cancer cell international
Published: April 22, 2024
Management and risk of upgrade of atypical ductal hyperplasia in the breast: A population-based retrospective cohort study.
Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
Published: February 28, 2024
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study.
Journal: The British journal of surgery
Published: October 20, 2023
Last Updated: 09/26/2026